Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00158067 · ClinicalTrials.gov registry record · Phase 2

Study of an External Responsive Neurostimulator System on Epileptiform Activity

A Phase 2 study of Epilepsy, sponsored by NeuroPace.

Completed
Registry status
Phase 2
Development phase
150
Enrollment target
5
Study locations

NCT00158067 is a Phase 2 study of Epilepsy that has completed, run by NeuroPace. The registered enrollment target is 150 participants, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (84% lower). The trial reports 5 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00158067, a Phase 2 study of Epilepsy, has completed, sponsored by NeuroPace.

COMPLETED
Registry status
Phase 2
Development phase
150 participants
Enrollment target
5
Study locations

Study Summary

This feasibility clinical investigation is designed to demonstrate that the NeuroPace external Responsive Neurostimulator (model eRNS-300) can safely deliver responsive electrical stimulation automatically to affect epileptiform activity. The eRNS-300 is based on an implantable neurostimulator that has been adapted for acute, external use in a hospital setting.

Conditions Studied

Epilepsy

Interventions

  • DEVICE external Responsive Neurostimulator (eRNS) System

Study Locations (5)

Arizona

  • Research Site - Scottsdale

Georgia

  • Research Site - Augusta

Maryland

  • Research Site - Baltimore

Minnesota

  • Research Site - Rochester

New York

  • Research Site - New York

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2002-03
Est. Completion 2008-03
Phase Phase 2

Sponsor

NeuroPace

8 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00158067

The ClinicalTrials.gov registry entry for NCT00158067 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (84% lower). The listed sponsor is NeuroPace, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Epilepsy appearing as the primary indexed condition, and to 1 intervention - of which external Responsive Neurostimulator (eRNS) System is the first listed.

NCT00158067 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Arizona, Georgia, Maryland.

Frequently Asked Questions

What is clinical trial NCT00158067 about?

NCT00158067 is a clinical study titled "Study of an External Responsive Neurostimulator System on Epileptiform Activity". This feasibility clinical investigation is designed to demonstrate that the NeuroPace external Responsive Neurostimulator (model eRNS-300) can safely deliver responsive electrical stimulation automatically to affect epileptiform activity. The eRNS-300 is based on an implantable neurostimulator that ...

What is the current status of trial NCT00158067?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 150 participants. The study started on 2002-03. Estimated completion is 2008-03.

What conditions does trial NCT00158067 study?

This clinical trial studies the following conditions: Epilepsy.

What interventions are being tested in trial NCT00158067?

The interventions under investigation include: external Responsive Neurostimulator (eRNS) System (DEVICE).

Who is sponsoring clinical trial NCT00158067?

This trial is sponsored by NeuroPace, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00158067 being conducted?

This trial has 5 study locations across Arizona, Georgia, Maryland, Minnesota, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Epilepsy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Epilepsy

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.